Sign in
4

Changes in Ownership

Viridian Therapeutics, Inc.\DE Filed Acc 0000899243-21-002488

Options or other derivatives

  • Chief Financial Officer acquired 311,785 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Leverone Jason A. Chief Financial Officer 2021-01-18 Grant or award · Employee Stock Option (right to buy) +311,785 311,785 D
Loading xslF345X03/doc4.xml…